Pain Management

Healio spoke with two clinicians from Johns Hopkins University about the psoriatic arthritis treatment landscape, specifically touching on JAK inhibitor and interleukin-6 agents.

A multidisciplinary approach is key to treating patients with corneal nerve dysfunction and neuropathic ocular pain, according to a speaker at Twin Cities Ocular Surface Disease Symposium.

Researchers identified multiple predictors of opioid overdose after an opioid prescription for chronic pain in a new study published in CMAJ.

Multiple diverse patient groups were less likely to have pain scores recorded or receive opioid or ketamine analgesia for pain compared with white patients, researchers found.

Treatment with evobrutinib in continuous, twice-daily dosing provided the lowest relapse rate and highest arrest of clinical worsening after 5 years in those with relapsing multiple sclerosis, according to data presented at ECTRIMS 2023.

ORLANDO — The CDC’s updated guidance on prescription opioids in 2022 were a step in the right direction, but nonopioid therapies should take a more “prominent role” in the management of pain, according to a speaker.

Continuous subcutaneous infusion of foslevodopa/foscarbidopa improved “on” time and reduced “off” time in those with Parkinson’s disease at 52 weeks, with a favorable safety and tolerability profile, per research from Neurology and Therapy.

SAN DIEGO — Non-pharmacologic approaches to pain management in rheumatology, like exercise and meditation, can be superior to pharmacologic strategies, according to a speaker at the 2023 Congress of Clinical Rheumatology West.

SAN DIEGO — Thoroughly documenting all patient interactions may help address physicians’ trepidation regarding opioid prescriptions, according to a speaker at the Congress of Clinical Rheumatology West.

September is National Sickle Cell Awareness Month.